Oncocyte Begins Manufacturing Transplant Blood Test
June 27, 2023 08:30 ET
|
Oncocyte Corporation
Over 1 million annual testing opportunities in US Q4 targeted for early access launch IRVINE, Calif., June 27, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics...
Oncocyte Reports First Quarter 2023 Financial Results
May 11, 2023 08:00 ET
|
Oncocyte Corporation
IRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the first quarter 2023, ended March 31,...
Oncocyte To Announce First Quarter 2023 Financial Results
April 27, 2023 16:59 ET
|
Oncocyte Corporation
IRVINE, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that it will release its first quarter 2023 financial...
Oncocyte Presents New Data at AACR
April 18, 2023 08:45 ET
|
Oncocyte Corporation
IRVINE, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that five posters of original research are being presented at...
Oncocyte Announces Reduction in Force
April 12, 2023 16:15 ET
|
Oncocyte Corporation
IRVINE, Calif., April 12, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced a reduction in force involving approximately 20% of its...
Oncocyte Announces Publication of DetermaIO Results from AtezoTRIBE Study in Metastatic Colorectal Cancer
April 07, 2023 08:24 ET
|
Oncocyte Corporation
IRVINE, Calif., April 07, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostic company, today announces the peer-reviewed publication of the results of a study...
Oncocyte Pricing of $13.86 Million Public Offering of Common Stock
April 03, 2023 08:00 ET
|
Oncocyte Corporation
IRVINE, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), (“Oncocyte” or the “Company”), a precision diagnostics company, announced today the entry into an agreement...
Oncocyte Reports Preliminary Fourth Quarter and Full Year 2022 Financial Results and Plans to File Form 12b-25 to Extend Filing Date of Its Form 10-K
March 31, 2023 17:00 ET
|
Oncocyte Corporation
IRVINE, Calif., March 31, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced plans to file a Form 12b-25 with the U.S. Securities and...
Oncocyte Announces Date Change for Fourth Quarter and Full Year 2022 Earnings Call
March 29, 2023 16:01 ET
|
Oncocyte Corporation
IRVINE, Calif., March 29, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that it has changed the date of its previously announced...
Oncocyte to Announce Fourth Quarter and Full Year 2022 Financial Results
March 15, 2023 16:01 ET
|
Oncocyte Corporation
IRVINE, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that it will release its fourth quarter and full year 2022...